Navigation Links
EUROPLASMA: Résultats consolidés 2012
Date:9/26/2013

si soutenue en 2012 qu'en 2011 mais avec une baisse des revenus compte tenu du montant exceptionnel de la commande Sharp/Air Liquide de plus de 10M€ comptabilisée sur les exercices 2010 et 2011.

Performance opérationnelle

Au 31/12/2012, L'EBITDA consolidé s'établit à (9 204) K€ contre 2 688 K€ au 31/12/2011. Les pertes opérationnelles du Groupe au cours de l'exercice 2012 proviennent des segments Energies Renouvelables et Déchets Dangereux et se décomposent comme suit :

  • le segment Energies Renouvelables présente un EBITDA négatif de (8 973) K€. Cette perte s'explique par l'accumulation des coûts d'exploitation liés à la période étendue de mise en route de l'usine CHO Morcenx, au coût de remplacement du gazéifieur défaillant de l'installation, et aux indemnités de report de la Take Over Date de l'usine. Ces frais ont été enregistrés dans les coûts à terminaison du contrat d'EPC en 2012, le rendant ainsi fortement déficitaire.
  • l'activité de Déchets Dangereux affiche un EBITDA négatif de (1 481) K€ dû essentiellement à l'arrêt de la production pendant plusieurs semaines imposé par les travaux de mise en conformité de la nouvelle zone de préparation de charges.

Les segments Etudes et ingénierie, torches et procédés et Air et gaz dégagent un EBITDA positif respectivement de 179 K€ et 1 071K€ contre respectivement 596 K€ et 1 718 K€ en 2011.

Résultat net

Le résultat net part du Groupe correspond à une perte de (20 091) K€ contre une perte de (1 341) K€ en 2011.

La branche Energies Renouvelables a, à elle seule, enregistré un résult
'/>"/>

SOURCE Europlasma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... 21, 2015  CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced positive updated results from ... for the treatment of unresectable glioblastoma multiforme (GBM), ... multisite trial is designed to investigate the preliminary ... tumors have progressed following prior treatment with surgery, ...
(Date:5/21/2015)... PA (PRWEB) May 21, 2015 ... has joined the firm as senior statistician and Principal, ... years of experience in the management and analysis of ... pharmaceutical and chemical industries. , “We’re delighted to have ... capabilities in data analytics,” said Dr. Philippe Cini, Group ...
(Date:5/20/2015)... MECHANICSBURG, Pa. , May 20, 2015 /PRNewswire/ ... announced that the Federal Trade Commission granted early ... (HSR) Antitrust Improvements Act of 1976, as amended, ... by MJ Acquisition Corporation, a joint venture that ... XII, L.P. As previously announced, MJ ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... MSEDMONTON, April 29 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), ... today announced that Mr. Kevin Giese, President and CEO, will ... development of a world class technology sector" as part of ... WHEN: Monday May 4th at ...
... April 29 In an effort to provide ... a New Jersey-based early-phase medical device company, has ... solution. The solution is designed to protect hospital ... life-threatening pathogens in healthcare facilities. It enables effective, ...
... - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS ... oncology, today announced it has received notification from the Nasdaq ... Rule 5450 (a) (1) relating to the maintenance of a ... was required to evidence a closing bid price of at ...
Cached Biology Technology:BioMS Medical to present at Alberta Economic Forum in Geneva 2Germgard's Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C difficile, and Influenza Virus 2
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... clinical researchers will present findings about a one-two punch ... the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ... is presenting data in two poster presentations that a ... percent of infectious airborne germs. Findings from these two ...
... Champaign, Ill., September 7, 2012 The University ... five new research teams joining the NASA Astrobiology Institute (NAI) ... five-year grant totaling approximately $8 million. Nigel Goldenfeld, ... theme at the Institute for Genomic Biology (IGB), will serve ...
... BUFFALO, N.Y. -- Tiny sea creatures called rhabdopleurids reside on ... of dead clams. Rhabdopleurid colonies are small, and the critters ... But they have lived this way -- and survived -- ... they have outlasted more elaborate species that also descended from ...
Cached Biology News:Research finds novel airborne germ-killing oral spray effective in fighting colds and flu 2University of Illinois at Urbana-Champaign awarded 5-year grant from NASA 2University of Illinois at Urbana-Champaign awarded 5-year grant from NASA 3Ancient, bottom-dwelling critter proves: Newer isn't always better 2
... BacVector Insect Cell Medium is optimized for ... Insect Cells. In this protein-free medium, Sf9 ... * 107 cells/ml with viabilities above 95%. ... assays, where color from X-gluc staining of ...
... is formuatled for the growth of ... Sf21 cells. Grace's Insect Mediu, Unsupplemented ... does not contain lactalbumin hydrosylate, and ... Grace's Insect Medium, Supplemented is formulated ...
TNM-FH Insect Medium 1 liter...
... Davison and Richard M. ... include: information on positive ... influenza and immunodeficiency viruses. ... of viral NA replication ...
Biology Products: